Bronchopulmonary Dysplasia (BPD) of the Newborn

Bronchopulmonary dysplasia (BPD) is a long-lasting lung problem that affects some premature babies. It happens when a baby is born early and the lungs are still immature. The baby often needs help to breathe with oxygen and machines. Oxygen and breathing machines save the baby’s life, but they can also irritate the tiny air sacs and blood vessels in the lungs. Over time, the lungs can grow with fewer, larger air sacs and fewer blood vessels. This means less surface area to move oxygen into the blood. The airway walls may get thick and stiff, and there is ongoing inflammation (irritation) and scarring. Doctors usually diagnose BPD at 36 weeks post-menstrual age (about the time a full-term pregnancy would be near its end) based on how much oxygen or breathing support the baby still needs. Some babies have mild BPD and need just a little oxygen. Others have moderate or severe BPD and need higher oxygen or machine support. BPD can also affect the heart and growth. Many babies get better with time as their lungs grow, but some need oxygen for months and careful follow-up.

Bronchopulmonary dysplasia (BPD) is a long-lasting lung disease that happens in very premature babies. It is most common in babies born before 32 weeks and in babies who needed help to breathe for many days. In BPD, the lungs did not finish growing their tiny air sacs (alveoli) and blood vessels. The lungs also got inflamed and stiff from illness and from the support needed to keep the baby alive (oxygen and ventilators). Because of this, the baby still needs extra oxygen or breathing support at 36 weeks’ postmenstrual age (about the time when very early babies would still be in the womb). BPD is not one single injury. It is the result of many small injuries during a time when the lungs are very immature. Over time, some babies improve a lot, but some have lasting breathing problems, more lung infections, or high pressure in the lung arteries (pulmonary hypertension).

Bronchopulmonary dysplasia (BPD) is a long-lasting lung problem that happens mostly in very small or very early babies who need oxygen and a breathing machine after birth. Their lungs are not fully grown. Air pressure and oxygen can irritate the tiny air sacs and the small airways. Inflammation, swelling, and scarring then make breathing hard. The lungs try to heal, but new growth can be uneven. Babies with BPD may breathe fast, need extra oxygen for weeks or months, and get tired with feeding. Some develop pulmonary hypertension (high blood pressure in the lungs). Most babies slowly improve as the lungs grow in the first 2–3 years of life, but they can have more colds, wheeze, and need careful follow-up. Early care in the NICU focuses on gentle ventilation, good nutrition, and preventing infection.

---

Other names

• Chronic lung disease of prematurity

• Neonatal chronic lung disease

• Evolving BPD (when the condition is developing in the NICU)

• “Classic” BPD (older pattern seen in larger preterm infants exposed to high oxygen and older ventilator settings)

• “New” BPD (current pattern in very small, very early infants with arrested lung development)

---

Types

1. Severity by oxygen/support at 36 weeks PMA
   Mild: room air. Moderate: need for <30% oxygen. Severe: ≥30% oxygen and/or positive pressure (CPAP, ventilator). This helps guide care and follow-up.

2. Classic vs. New BPD
   Classic BPD shows more scarring and airway damage in babies born a little later in pregnancy. New BPD shows fewer but larger air sacs and fewer blood vessels in babies born very early. This reflects different patterns of lung injury and growth arrest.

3. Ventilation-dependent vs. CPAP/oxygen-dependent
   Some babies cannot come off the ventilator and have severe disease. Others can breathe without a tube but still need CPAP/high-flow or extra oxygen. This helps plan weaning.

4. Pulmonary hypertension–associated BPD
   Some babies develop high blood pressure in the lungs (pulmonary hypertension). This raises the workload on the right side of the heart and increases risks. It requires heart ultrasound screening and targeted treatment.

5. Airway-predominant phenotype
   Wheeze, bronchospasm, and airway collapsibility dominate. These babies may respond to inhaled therapies and careful airway support.

6. Parenchymal/vascular-predominant phenotype
   The main problem is fewer air sacs and fewer blood vessels, causing low oxygen levels and poor gas exchange. Oxygen and growth support are central.

7. Growth-restricted phenotype
   Poor weight gain and small size for age go along with BPD. Nutrition, calories, and fluid balance are key parts of care.

8. Relapsing/exacerbation-prone pattern
   Some infants have frequent setbacks with infections or when weaning oxygen. Care plans focus on prevention, vaccination, reflux control, and home monitoring.

---

Causes and risk factors

1. Prematurity
   The main cause. Lungs finish important development late in pregnancy. When birth happens early, air sacs and blood vessels are not fully formed. Early lungs are easier to injure and harder to heal.

2. Very low birth weight
   Babies under 1,500 g, especially under 1,000 g, have fragile lungs and less reserve. They need more support and have a higher chance of BPD.

3. Mechanical ventilation (breathing machine)
   Positive pressure saves lives but can stretch and irritate the lungs (barotrauma/volutrauma). Repeated high pressures and volumes harm delicate air sacs.

4. Oxygen toxicity
   High oxygen can create “free radicals” that damage lung tissue. Modern care uses the lowest oxygen needed and careful targets to limit this risk.

5. Prenatal inflammation (chorioamnionitis)
   Infection or inflammation around the time of birth can “prime” the lungs for injury. Once born, the lungs react more strongly to oxygen and ventilation.

6. Postnatal infections (sepsis, pneumonia)
   Infections trigger inflammation and can worsen lung injury. They also prolong ventilator days and oxygen needs.

7. Patent ductus arteriosus (PDA)
   A persistent open vessel between the aorta and pulmonary artery lets too much blood flow to the lungs. This causes lung edema and makes breathing support harder.

8. Intrauterine growth restriction (IUGR)
   Babies who grew poorly in the womb often have smaller lungs and blood vessels. Their lungs may be more prone to “arrested” development after birth.

9. Insufficient antenatal steroids
   Steroids given to the mother before very preterm birth help mature the lungs. Without them, the baby may need more support and have higher BPD risk.

10. Surfactant deficiency or delayed surfactant
    Surfactant keeps air sacs open. When it is missing or late, the lungs collapse and need higher pressures, adding injury risk.

11. Fluid overload
    Too much fluid leads to lung swelling, making gas exchange worse and requiring more support.

12. Gastroesophageal reflux and micro-aspiration
    Small amounts of stomach content that reach the airway can inflame lungs and trigger setbacks.

13. Vitamin A deficiency
    Vitamin A supports airway and alveolar lining health. Low levels are linked to higher BPD risk in very preterm babies.

14. Genetic susceptibility
    Not all infants with similar care develop BPD. Differences in genes that govern inflammation and repair may change risk.

15. Male sex
    Male preterm infants have a slightly higher risk, possibly due to slower lung maturation.

16. Repeated intubations
    Each intubation can irritate the airway and increase exposure to ventilator pressures.

17. High ventilator settings early after birth
    Large breaths and high pressures can start a cycle of injury. Gentle ventilation strategies try to avoid this.

18. Environmental tobacco smoke exposure
    Smoke exposure before or after birth irritates the lungs, worsens symptoms, and increases hospital visits.

19. Low early nutrition and calories
    Growing lungs need energy and protein. Poor intake slows repair and alveolar growth.

20. Viral infections (e.g., RSV, rhinovirus)
    Viruses can cause severe lower airway disease in infants with BPD, raising oxygen needs and causing hospitalizations.

---

Common symptoms and signs

1. Fast breathing (tachypnea)
   The baby breathes quickly to try to get enough oxygen through stiff or under-developed lungs.

2. Chest retractions
   Skin between the ribs and at the neck pulls in with each breath because breathing effort is high.

3. Wheezing
   Narrow, irritated airways make a whistling sound. It may get worse with colds.

4. Crackles on listening
   The care team may hear popping sounds with a stethoscope due to small airways opening late.

5. Low oxygen levels (desaturation)
   The oxygen monitor may drop, especially during sleep or feeding. Extra oxygen may be needed.

6. Gray or blue color (cyanosis)
   Lips or skin may look bluish when oxygen is low.

7. Cough
   The baby may cough because of airway irritation, secretions, or reflux.

8. Poor feeding
   Babies tire easily while eating because breathing takes a lot of energy.

9. Slow weight gain
   Calories go to the hard work of breathing, leaving fewer for growth unless nutrition is boosted.

10. Sweating with feeds
    This is a sign of high effort during feeding and sometimes hints at heart strain.

11. Apnea or bradycardia spells
    Short pauses in breathing or slow heart rate can occur, especially early on.

12. Frequent colds or lower airway infections
    Babies with BPD often have more severe symptoms when they catch viruses.

13. Swelling or signs of right heart strain
    Severe cases with pulmonary hypertension may show liver edge swelling or poor perfusion.

14. Exercise intolerance later in infancy
    As the child grows, they may tire easily during play because lungs exchange less oxygen.

15. Sleep problems
    Some infants have drops in oxygen overnight or light sleep fragmentation, calling for monitoring.

---

Diagnostic tests

A) Physical examination

1. Work of breathing assessment
   The clinician looks for fast breathing, retractions, nasal flaring, and grunting. These signs show how hard the baby is working to move air and whether support needs adjusting.

2. Auscultation (listening to the lungs and heart)
   Wheeze, crackles, or decreased breath sounds guide treatment. Heart sounds can suggest pulmonary hypertension or fluid overload.

3. Growth and nutrition check
   Weight, length, and head growth trends show whether nutrition is enough for lung repair. Poor growth suggests higher oxygen needs and risk of setbacks.

4. Signs of right heart strain
   The provider looks for liver edge enlargement, swelling, cool extremities, or a loud second heart sound. These may signal pulmonary hypertension.

B) Bedside/manual tests

5. Continuous pulse oximetry
   A small sensor checks oxygen levels. This helps set safe oxygen targets and guides weaning.

6. Room-air (weaning) challenge
   Staff briefly lowers oxygen under close monitoring to see if the baby can keep safe saturations. It helps decide readiness for discharge without oxygen.

7. Silverman-Andersen or similar respiratory distress score
   A simple score using observation (retractions, grunting, etc.) helps track changes day to day.

8. Feeding observation test
   Nurses watch a full feed while monitoring oxygen and heart rate. Drops in oxygen or fatigue suggest the need for pacing, thicker feeds, or more support.

C) Laboratory and pathological tests

9. Arterial/capillary blood gas
   Measures oxygen and carbon dioxide in the blood and the blood’s acidity. It shows if ventilation is enough or if CO₂ is trapped.

10. Complete blood count (CBC)
    Low hemoglobin reduces oxygen delivery; infection raises white cells and can worsen breathing.

11. C-reactive protein (CRP) and blood cultures (if ill)
    These look for infection. Infection raises oxygen needs and can trigger setbacks.

12. Electrolytes and diuretic monitoring
    Babies on diuretics need checks for sodium, potassium, and chloride to avoid rhythm problems and weakness.

13. BNP/NT-proBNP (heart strain markers)
    Higher levels can support a diagnosis of pulmonary hypertension or right heart stress, alongside imaging.

14. Vitamin A and nutrition labs (selected cases)
    If growth is poor, checking micronutrients helps tailor supplementation to support lung repair.

D) Electrodiagnostic/physiologic studies

15. Electrocardiogram (ECG)
    Looks for right-sided heart strain from pulmonary hypertension and screens for rhythm issues, especially with certain medicines.

16. Overnight oximetry or limited polysomnography
    Measures oxygen levels during sleep to see if extra oxygen is needed at night and to detect frequent dips.

17. Capnography (end-tidal CO₂) when available
    Non-invasive tracking of CO₂ helps assess ventilation and risk of CO₂ retention during weaning.

E) Imaging tests

18. Chest X-ray
    Common first test. In BPD it may show patchy areas, streaky lines, and areas of overinflation next to scarring. It also helps rule out collapse, fluid overload, or pneumonia.

19. Echocardiography (heart ultrasound)
    Key test to screen for pulmonary hypertension. It estimates pressures in the lung arteries and checks heart function to guide therapy.

20. High-resolution chest CT (selected severe cases)
    Not routine because of radiation, but can clarify the pattern of lung disease in complex, severe cases or before advanced therapies.

Non-Pharmacological Treatments (therapies & others)

1) Gentle ventilation strategy (lung-protective breathing support)
Description: Gentle ventilation uses the lowest pressure and oxygen levels that still keep the baby safe. The team avoids “over-stretching” the lungs. They choose modes like CPAP, NIPPV, or carefully set ventilator pressures. They allow slightly higher carbon dioxide (“permissive hypercapnia”) when safe to reduce lung injury. Alarms and frequent checks help keep settings just right. Nurses watch the baby’s chest movement, color, comfort, and blood gases. The goal is to prevent new injury while the lungs heal and grow. This method can shorten the time on a breathing machine, lower oxygen needs, and reduce later scarring. Parents often see fewer alarms and a calmer baby when the settings match the baby’s needs.
Purpose: Reduce ventilator-induced lung injury and oxygen toxicity.
Mechanism: Limits barotrauma/volutrauma and oxidative stress, lowering inflammation in immature lung tissue.
Evidence note: Lung-protective ventilation is a cornerstone of modern NICU care supported by neonatal guidelines and trials.

2) Early CPAP or NIPPV instead of invasive ventilation
Description: CPAP (continuous positive airway pressure) and NIPPV (non-invasive positive pressure ventilation) deliver gentle air support through small prongs or a mask. This keeps air sacs open and reduces the work of breathing without a tube in the windpipe. Early use can avoid intubation, which lowers the chance of lung injury, infection, and later BPD. Staff fit the interface carefully to prevent skin injury and leaks. Frequent breaks for skin care and repositioning are part of the plan.
Purpose: Stabilize breathing while avoiding endotracheal ventilation.
Mechanism: Maintains functional residual capacity and reduces atelectasis, thus lowering oxygen need and shear stress.
Evidence note: Multiple neonatal studies link early non-invasive support with less BPD compared with prolonged invasive ventilation.

3) Oxygen targeting with pulse oximetry protocols
Description: Nurses and doctors use written oxygen-saturation ranges to avoid both low oxygen (dangerous for the brain and heart) and high oxygen (damaging to the lungs and eyes). Continuous pulse oximetry guides small, frequent adjustments. Alarms are set to alert staff before the baby stays too high or too low for long. Parents learn why the oxygen range matters and help keep the baby calm, since crying can drop or raise oxygen quickly.
Purpose: Give “just-right” oxygen for safety and lung protection.
Mechanism: Minimizes oxidative stress and free-radical injury that worsen inflammation and BPD.
Evidence note: Targeted oxygen strategies are standard of care and reduce oxygen toxicity and retinopathy risks.

4) Kangaroo care (skin-to-skin contact)
Description: The baby is placed upright on the parent’s bare chest with warm blankets on top. Sessions are frequent and long as the baby tolerates. Skin-to-skin helps the baby keep a steady temperature, breathe more evenly, and stay calm. Parents learn their baby’s cues and gain confidence. Feeding often improves. Many babies need less oxygen during sessions. Over time, this aids growth and can shorten stays in the NICU.
Purpose: Stabilize breathing and heart rate; promote growth; support bonding.
Mechanism: Reduces stress hormones, improves regulation of breathing and temperature, and may enhance vagal tone.
Evidence note: Strong evidence supports kangaroo care for preterm stability and developmental outcomes.

5) Optimal positioning and handling (developmental care)
Description: The baby is positioned with gentle flexion support (nesting), head midline, and shoulders forward to ease breathing. Nurses limit unnecessary handling, dim lights, and reduce noise. Cue-based care times are used. This supports steady oxygen levels and reduces energy use. Parents learn safe holds that keep the airway open and chest free.
Purpose: Lower work of breathing and conserve calories.
Mechanism: Improves chest wall mechanics, reduces desaturations, and decreases stress-induced oxygen swings.
Evidence note: Developmental care bundles improve physiologic stability in preterm infants.

6) Nutritional optimization with fortified human milk
Description: Human milk is the base. Because tiny babies need more protein, minerals, and calories, milk is fortified to meet higher targets. Dietitians monitor weight, length, and head growth weekly. Extra protein and calories help repair lung tissue and build new alveoli. Adequate vitamin A, D, calcium, and phosphorus support lung and bone growth. Feeds are advanced carefully to avoid feeding intolerance.
Purpose: Support lung healing and growth; prevent growth failure.
Mechanism: Provides substrates for alveolarization, antioxidant defenses, and respiratory muscle development.
Evidence note: Human milk and targeted fortification are associated with better outcomes and possibly lower BPD risk.

7) Feeding support and swallow safety
Description: Many babies with BPD tire with feeding or have reflux. Speech/feeding therapists assess suck-swallow-breath coordination. They may use slower flow nipples, pacing, side-lying feeding, and shorter, more frequent feeds. If needed, temporary tube feeding provides nutrition without exhausting the baby.
Purpose: Ensure safe, efficient feeding while protecting breathing.
Mechanism: Matches feeding demands to respiratory capacity, preventing desaturations and aspiration.
Evidence note: Feeding interventions reduce events and support growth in infants with respiratory disease.

8) Infection prevention bundle
Description: Strict hand hygiene, careful central line use, breast-milk feeding, and vaccination planning reduce infections. Visitors with colds stay away. During viral seasons, families learn masking and hygiene rules. Infections can trigger big setbacks in BPD.
Purpose: Prevent pneumonia and viral bronchiolitis that worsen BPD.
Mechanism: Lowers inflammatory hits that amplify lung damage.
Evidence note: Bundled NICU infection-control practices reduce sepsis and respiratory infections.

9) Thermoregulation and humidity control
Description: Stable warmth and humidity reduce stress and water loss from the lungs and skin. Incubators and warmers are adjusted often. Good temperature control keeps breathing steadier and saves calories for growth.
Purpose: Maintain physiologic stability to aid lung healing.
Mechanism: Reduces metabolic demand and prevents cold-stress-related desaturations.
Evidence note: Standard NICU practice with demonstrated impact on stability and growth.

10) Early, gentle physical and respiratory therapy
Description: Therapists use gentle range-of-motion, positioning, and cue-based activity to support posture and breathing mechanics. As babies grow, tummy time and midline hand play improve chest wall control. Some centers use gentle chest physiotherapy if secretions are an issue.
Purpose: Improve breathing efficiency and prevent stiffness.
Mechanism: Enhances thoracoabdominal synchrony and secretion clearance.
Evidence note: Developmentally supportive therapy improves functional outcomes.

11) Family training and home-oxygen education
Description: Before discharge, families learn oxygen safety, monitor use, nasal cannula care, and what to do during colds. They practice with the equipment, alarms, and portable tanks or concentrators. Clear action plans lower emergency visits.
Purpose: Safe home care and fewer readmissions.
Mechanism: Consistent oxygen delivery and early illness response.
Evidence note: Structured discharge teaching improves home management.

12) RSV and viral exposure reduction strategies
Description: Families avoid crowded indoor spaces in peak season, keep hands clean, and consider prophylaxis options recommended by clinicians. Siblings learn to wash hands and cover coughs.
Purpose: Prevent severe bronchiolitis that can be dangerous in BPD.
Mechanism: Reduces viral load exposures.
Evidence note: Preventive strategies lower hospitalization risk.

13) Reflux and aspiration minimization without routine acid suppression
Description: Positioning (left-side or upright after feeds), careful volumes, and thickening when appropriate can help. Routine acid blockers are not used unless clearly needed.
Purpose: Limit micro-aspiration that worsens lung irritation.
Mechanism: Reduces gastro-pulmonary reflux events.
Evidence note: Non-pharmacologic reflux measures are first-line in infants.

14) Anemia avoidance and restrictive transfusion strategy
Description: Teams aim to prevent anemia with iron and minimize blood draws. Transfusions are given only when benefits outweigh risks.
Purpose: Keep oxygen delivery adequate without excess transfusions.
Mechanism: Maintains hemoglobin while avoiding transfusion-related complications.
Evidence note: Restrictive strategies are safe and common in preterm care.

15) Fluid management with careful intake/output
Description: Babies with BPD can hold fluid in the lungs. Daily weights, strict intake/output, and tailored fluids help prevent edema.
Purpose: Reduce lung water and work of breathing.
Mechanism: Keeps interstitial lung fluid low.
Evidence note: Conservative fluid strategies lower pulmonary edema risk.

16) Sleep-friendly NICU routines
Description: Clustered care, dim lights at night, and noise control help the baby rest. Better sleep supports growth and breathing regularity.
Purpose: Reduce stress and energy use.
Mechanism: Improves autonomic stability and repair processes.
Evidence note: Developmental care practices improve physiologic stability.

17) Multidisciplinary BPD team rounds
Description: Neonatologists, nurses, respiratory therapists, dietitians, pharmacists, and therapists round together to adjust the plan daily.
Purpose: Coordinate care and reduce practice variation.
Mechanism: Rapid, aligned decisions reduce complications.
Evidence note: Team-based care improves complex neonatal outcomes.

18) Early hearing and vision follow-up
Description: Babies with BPD need early checks for hearing and eye health. Good hearing and vision help development and feeding progress.
Purpose: Detect treatable issues early.
Mechanism: Screening and timely intervention support neurodevelopment.
Evidence note: Standard preterm follow-up guidelines.

19) Immunization on schedule
Description: Vaccines are given by chronological age unless a medical reason delays them. Vaccines prevent infections that could trigger serious lung setbacks.
Purpose: Protect against preventable disease.
Mechanism: Immune priming reduces severe respiratory illness.
Evidence note: Strong consensus supports timely vaccination in preterm infants.

20) Parent mental-health and social-support services
Description: BPD care is a marathon. Social workers, counselors, and peer groups reduce stress and help with home oxygen, transport, and appointments. Strong family support improves the baby’s outcomes.
Purpose: Sustain family resilience and adherence.
Mechanism: Reduces caregiver burnout and improves daily care quality.
Evidence note: Family-centered NICU models improve outcomes and satisfaction.

---

Drug Treatments

Important safety note: Many medications in BPD are off-label in neonates. Doses and timing must be individualized by a neonatologist. I provide common purposes/mechanisms and typical dosing ranges where widely used in practice; these are educational only.

1) Caffeine citrate
Class: Respiratory stimulant/xanthine.
Dosage/Time: Commonly a 20 mg/kg loading dose (caffeine citrate), then 5–10 mg/kg once daily; adjusted by team.
Purpose: Treats apnea of prematurity, reduces intermittent hypoxemia.
Mechanism: Blocks adenosine receptors, stimulates respiratory drive, improves diaphragmatic contractility.
Side effects: Tachycardia, irritability, feeding intolerance, rare seizures.
Description : Caffeine helps babies breathe more steadily by stimulating the brain’s breathing center and making the breathing muscles work better. Fewer pauses in breathing mean fewer drops in oxygen, less need for high ventilator support, and possibly lower risk of BPD. It also improves readiness to come off ventilation earlier. Nurses watch heart rate, sleep, and feeding tolerance. Blood levels are checked if concerns arise. Because caffeine has a long half-life in preterm babies, once-daily dosing is typical. The care team adjusts the dose based on weight changes and clinical response. Many units start caffeine early for very small babies who are likely to have apnea. Parents often notice fewer alarms and smoother feeds as apnea decreases.

2) Vitamin A (retinyl palmitate, IM)
Class: Vitamin/antioxidant.
Dosage/Time: Intermittent intramuscular dosing protocol in very low birth-weight infants per unit protocol.
Purpose: Lowers BPD risk in extremely preterm infants.
Mechanism: Supports epithelial integrity and lung development; antioxidant role.
Side effects: Injection discomfort, rare toxicity at high doses.
Description: Vitamin A supports lung lining cells and helps normal lung growth. In very early babies, levels are often low. Supplemental vitamin A, given by specific NICU protocols, can reduce BPD or death in high-risk infants. The shot is quick; nurses use pain-relief steps. Monitoring ensures safe dosing.

3) Budesonide (inhaled) ± surfactant instillation approaches
Class: Inhaled corticosteroid.
Dosage/Time: Unit-specific dosing if used; often research/center-protocol-driven.
Purpose: Reduce airway inflammation and oxygen needs.
Mechanism: Local anti-inflammatory effects in airways/alveoli.
Side effects: Oral thrush, growth concerns with prolonged systemic absorption (monitor).
Description: Inhaled steroids may calm airway inflammation and ease breathing, potentially lowering oxygen needs. Some centers study budesonide mixed with surfactant early in life; practices vary. Decisions are individualized.

4) Dexamethasone (systemic, short course)
Class: Systemic corticosteroid.
Dosage/Time: Short, tapering courses for infants with severe BPD who cannot wean from ventilation; exact protocols vary.
Purpose: Facilitate extubation, reduce inflammation.
Mechanism: Potent anti-inflammatory action reduces lung edema and airway reactivity.
Side effects: Hyperglycemia, hypertension, GI bleeding, infection risk, growth/skeletal and neurodevelopment concerns—use cautiously.
Description: Short courses can help a baby come off a ventilator by shrinking airway swelling and improving lung mechanics. Because of possible long-term side effects, teams use the lowest effective dose for the shortest time, after careful discussion with parents.

5) Hydrocortisone (systemic, physiologic/low-dose strategies)
Class: Systemic corticosteroid.
Dosage/Time: Low-dose courses early or later per protocol; details vary.
Purpose: Reduce inflammation and support blood pressure when needed.
Mechanism: Anti-inflammatory and mineralocorticoid effects.
Side effects: Similar to steroids; monitor glucose, blood pressure, infection risk.
Description: Hydrocortisone is sometimes chosen as a gentler systemic steroid option to help with lung inflammation and to support blood pressure in fragile preterm infants. Use is individualized and closely watched.

6) Chlorothiazide (± spironolactone)
Class: Thiazide diuretic (± potassium-sparing).
Dosage/Time: Commonly 10–20 mg/kg/dose every 12 hours for chlorothiazide; spironolactone 1–3 mg/kg/day divided—per NICU protocol.
Purpose: Reduce lung fluid and improve breathing.
Mechanism: Promotes diuresis, lowers interstitial lung water, improves compliance.
Side effects: Electrolyte changes (Na, K), dehydration, metabolic effects.
Description: Diuretics help babies who retain fluid and show puffy lungs on exam or X-ray. Lowering extra lung water can ease breathing and decrease oxygen needs. Electrolytes and weight are checked often.

7) Furosemide (intermittent dosing)
Class: Loop diuretic.
Dosage/Time: Intermittent 0.5–1 mg/kg IV/PO; frequency varies; avoid routine daily long-term use due to risks.
Purpose: Short-term relief of pulmonary edema.
Mechanism: Strong diuresis via loop of Henle; rapid reduction in lung water.
Side effects: Electrolyte loss, ototoxicity (with IV/high dose), bone mineral loss.
Description: Used as “rescue” diuretic for acute fluid overload or difficult weaning. Close monitoring is essential.

8) Albuterol (salbutamol) inhaled
Class: Short-acting β2-agonist bronchodilator.
Dosage/Time: Inhaled or nebulized per weight and response.
Purpose: Reduce wheeze and airway spasm.
Mechanism: Relaxes airway smooth muscle.
Side effects: Tachycardia, tremor, irritability.
Description: In some infants with reactive airways, albuterol can temporarily improve airflow and reduce work of breathing. Response is variable; clinicians trial and reassess.

9) Ipratropium bromide inhaled
Class: Anticholinergic bronchodilator.
Dosage/Time: Inhaled per protocol, often with β2-agonist.
Purpose: Add-on bronchodilation.
Mechanism: Blocks muscarinic receptors to reduce bronchoconstriction.
Side effects: Dry mouth, tachycardia.
Description: Sometimes used with albuterol when a baby shows clear bronchospasm.

10) Sildenafil (for BPD-associated pulmonary hypertension)
Class: PDE-5 inhibitor (pulmonary vasodilator).
Dosage/Time: Weight-based oral dosing; specialist guidance and echocardiography monitoring mandatory.
Purpose: Lower high pressure in lung vessels.
Mechanism: Increases cGMP to relax pulmonary vascular smooth muscle.
Side effects: Hypotension, reflux, flushing; drug interactions.
Description: In select babies with pulmonary hypertension, sildenafil can improve oxygenation and reduce right-heart strain. Multidisciplinary oversight is essential.

11) Inhaled nitric oxide (iNO) in select cases
Class: Pulmonary vasodilator gas.
Dosage/Time: Inhaled ppm per protocol; weaned carefully.
Purpose: Improve oxygenation in ventilation-dependent infants with pulmonary hypertension or severe V/Q mismatch.
Mechanism: Selective pulmonary vasodilation in ventilated lung units.
Side effects: Methemoglobinemia, nitrogen dioxide formation; monitor closely.
Description: Used selectively; benefits depend on phenotype and response testing.

12) Diuretic: Bumetanide (specialist use)
Class: Loop diuretic.
Dosage/Time: Low dose IV/PO per protocol; close monitoring.
Purpose: Alternative loop diuretic when furosemide not ideal.
Mechanism: Similar to furosemide but more potent.
Side effects: Electrolyte loss, ototoxicity risk.
Description: Specialist-guided use only, with labs and hearing vigilance.

13) Azithromycin (targeting Ureaplasma when indicated)
Class: Macrolide antibiotic/anti-inflammatory properties.
Dosage/Time: Short course per weight; only with clear indication.
Purpose: Treat suspected/confirmed Ureaplasma or pro-inflammatory airway colonization in research-guided settings.
Mechanism: Antimicrobial plus modulation of inflammatory cytokines.
Side effects: GI upset, QT prolongation (rare).
Description: Use is center-specific and evidence is evolving.

14) Palivizumab / nirsevimab (RSV prophylaxis—seasonal)
Class: Monoclonal antibody against RSV (nirsevimab: long-acting).
Dosage/Time: Single-season dosing per national guidance.
Purpose: Prevent severe RSV disease and hospitalization.
Mechanism: Neutralizes RSV to prevent lower airway infection.
Side effects: Injection reactions, very rare hypersensitivity.
Description: Recommended for many infants with BPD entering RSV season to reduce severe bronchiolitis.

15) Montelukast (select centers, limited evidence)
Class: Leukotriene receptor antagonist.
Dosage/Time: Oral, research/center-specific use only.
Purpose: Attempt to reduce airway inflammation/reactivity.
Mechanism: Blocks leukotriene-mediated bronchoconstriction/inflammation.
Side effects: Sleep/mood changes (rare), GI upset.
Description: Evidence in BPD is limited; not routine.

16) Dornase alfa (DNase) nebulized in select phenotypes
Class: Mucolytic enzyme.
Dosage/Time: Nebulized per protocol, off-label.
Purpose: Thin sticky secretions to ease clearance.
Mechanism: Breaks down extracellular DNA in mucus.
Side effects: Cough, irritation.
Description: Considered in babies with thick secretions and atelectasis; response varies.

17) Hypertonic saline nebulization (3% or higher)
Class: Osmotic mucolytic.
Dosage/Time: Nebulized per protocol, trial-based.
Purpose: Hydrate mucus to improve clearance.
Mechanism: Draws water into airway surface liquid.
Side effects: Bronchospasm (premedicate), cough.
Description: Trialed cautiously with bronchodilator cover in reactive infants.

18) Iron supplementation
Class: Micronutrient.
Dosage/Time: Typically 2–4 mg/kg/day elemental iron; individualized.
Purpose: Prevent or treat anemia to improve oxygen delivery.
Mechanism: Supports hemoglobin synthesis and erythropoiesis.
Side effects: Dark stools, constipation.
Description: Essential for growth and oxygen transport; dosing tailored to labs and feed type.

19) Vitamin D supplementation
Class: Micronutrient.
Dosage/Time: Usual preterm targets per unit protocol.
Purpose: Bone health and immune support; possible lung benefits.
Mechanism: Regulates calcium/phosphate and may modulate inflammation.
Side effects: Rare hypercalcemia at high doses.
Description: Standard micronutrient support in preterm care.

20) Proton-pump inhibitor or H2-blocker (only for proven indications)
Class: Acid suppression.
Dosage/Time: Lowest effective dose; reassess frequently.
Purpose: Treat true erosive esophagitis/GERD complications.
Mechanism: Reduces gastric acid production.
Side effects: Infection risk, microbiome changes; use sparingly.
Description: Not routine for BPD; reserved for clear diagnoses to avoid harm.

---

Dietary Molecular Supplements

These are nutritional adjuncts used under medical supervision. In preterm infants, all supplements must be clinician-directed and integrated into milk/fortifier plans.

1) Docosahexaenoic acid (DHA)
Dose: Included via fortified human milk or specialized preterm formulas per dietitian guidance.
Function: Supports brain and retinal development; potential anti-inflammatory lung effects.
Mechanism: Modulates cell membranes and eicosanoid signaling, possibly reducing airway inflammation.
Long description : DHA is a long-chain omega-3 fat that becomes part of cell membranes in the brain, eyes, and lungs. In preterm infants, stores are low because most DHA transfer happens late in pregnancy. Dietitians provide DHA through human milk with targeted fortification or specialized formulas. In the lungs, DHA may tilt inflammatory pathways toward resolution mediators. While the main proven benefits are neurodevelopmental and visual, better inflammatory balance may help fragile lungs tolerate stress. Dosing follows neonatal nutrition guidelines and is adjusted with total fat intake and growth. Monitoring includes growth patterns, feeding tolerance, and overall nutrient balance.

2) Arachidonic acid (ARA)
Dose: Balanced with DHA in milk fortification/formula.
Function: Structural lipid for growth and immune function.
Mechanism: Supports membrane signaling; balanced DHA:ARA ratios may optimize outcomes.
Description: ARA complements DHA to support growth and immune responses. Balanced provision is standard in preterm nutrition.

3) Vitamin A (enteral support in addition to IM protocols)
Dose: Dietitian-guided enteral vitamin A to meet recommended intakes.
Function: Epithelial integrity and antioxidant support.
Mechanism: Retinoids regulate gene expression for lung development.
Description: Enteral vitamin A supports daily needs while IM dosing addresses deficiency in select infants.

4) Vitamin D
Dose: Per preterm recommendations to achieve target serum 25-OH D.
Function: Bone mineralization; immune modulation.
Mechanism: Nuclear receptor signaling affects calcium balance and inflammation.
Description: Adequate vitamin D prevents osteopenia of prematurity and may support immune health.

5) Vitamin E
Dose: Provided within fortifiers/formulas at safe ranges.
Function: Antioxidant protecting cell membranes from oxidative stress.
Mechanism: Scavenges free radicals generated by oxygen therapy.
Description: Careful dosing avoids deficiency or excess; used as part of balanced antioxidant support.

6) Selenium
Dose: Micronutrient included in preterm parenteral/enteral mixes.
Function: Antioxidant enzyme cofactor (glutathione peroxidase).
Mechanism: Reduces peroxide-mediated tissue injury.
Description: Adequate selenium supports antioxidant systems in oxygen-exposed lungs.

7) Choline
Dose: Fortified feeds meeting preterm targets.
Function: Membrane phospholipids (e.g., surfactant components) and neurotransmission.
Mechanism: Supports phosphatidylcholine synthesis; crucial for lung surfactant.
Description: Ensures substrate for surfactant and growth.

8) Protein modulars (whey protein)
Dose: Added to human milk to achieve higher g/kg/day protein goals.
Function: Tissue repair and alveolar growth.
Mechanism: Provides amino acids for structural proteins and enzymes.
Description: Adequate protein is key for lung growth and respiratory muscle strength.

9) Medium-chain triglycerides (MCT oil)
Dose: Carefully titrated caloric additive.
Function: Energy dense; easy absorption.
Mechanism: Absorbed directly via portal vein; spares effort in fat digestion.
Description: Helps meet high calorie needs without large volumes.

10) Zinc
Dose: Supplement to meet preterm requirements.
Function: Growth, wound healing, immune function.
Mechanism: Cofactor for enzymes and transcription factors.
Description: Low zinc impairs growth; replacement supports catch-up and immunity.

---

Drugs for Immunity/Regenerative/Stem-Cell Oriented Purposes

(All investigational or specialist-directed in this population; mechanisms summarized; do not use without neonatal specialist oversight.)

1) Erythropoiesis-stimulating agents (ESAs) with iron
Dose: Protocol-based; varies.
Function: Improve red-cell mass to enhance oxygen delivery.
Mechanism: Stimulates erythroid progenitors; may reduce transfusions.
100-word description: ESAs aim to support red blood cell production in preterm infants who face frequent lab draws and low marrow reserves. Better hemoglobin may improve tissue oxygen delivery and energy for growth, indirectly easing respiratory load. Use is individualized, combined with iron, and monitored with labs to avoid excess hemoglobin or hypertension. Evidence for direct BPD benefit is mixed; main role is transfusion reduction.

2) N-acetylcysteine (antioxidant precursor)
Dose: Research/center-specific.
Function: Boosts glutathione defenses.
Mechanism: Replenishes intracellular glutathione to neutralize oxidative stress.
Description: Considered in trials or protocols to limit oxygen-induced injury. Clinical use is limited.

3) Omega-3–rich lipid emulsions (parenteral nutrition context)
Dose: As part of PN; specialist dosing.
Function: Anti-inflammatory lipid profile.
Mechanism: Alters eicosanoid production toward pro-resolving mediators.
Description: Used in PN to improve liver and inflammatory profiles; pulmonary effects are indirect.

4) Probiotics (select centers; strain-specific)
Dose: Center-specific strains/doses.
Function: Gut barrier and immune modulation.
Mechanism: Microbiome effects may reduce systemic inflammation and sepsis risk.
Description: Evidence supports NEC prevention with certain strains; pulmonary benefits are indirect.

5) Stem-cell–derived therapies (mesenchymal stromal cells—investigational)
Dose: Clinical trials only.
Function: Regenerative/anti-inflammatory signaling.
Mechanism: Paracrine factors may reduce lung inflammation and promote repair.
Description: Promising in early studies but not standard; available only in trials.

6) Immunoprophylaxis against RSV (nirsevimab/palivizumab)
Dose: As per seasonal guidance.
Function: Infection prevention to protect fragile lungs.
Mechanism: Neutralizes RSV, preventing severe lower respiratory disease.
Description: Key for BPD infants before discharge into RSV season; reduces hospitalizations.

---

Surgeries/Procedures (why done, how)

1) Tracheostomy (for severe, prolonged ventilation needs)
Procedure: Surgical opening in the neck to place a tracheostomy tube into the windpipe.
Why done: For babies who cannot be weaned from ventilation due to severe BPD or airway issues. It allows safer long-term ventilation, easier secretion care, and improved comfort. Families receive extensive training. Multidisciplinary planning is essential.

2) Gastrostomy tube (G-tube) placement
Procedure: Small feeding tube placed into the stomach through the abdominal wall.
Why done: For babies who need long-term supplemental feeding because oral feeds cause desaturations, poor growth, or aspiration risk. It lowers feeding stress, supports growth, and may reduce hospital visits.

3) Nissen fundoplication (select cases)
Procedure: Wrap upper stomach around the lower esophagus to reduce reflux.
Why done: Considered when severe reflux causes repeated aspiration/exacerbations despite maximal medical/positioning therapy. Decisions weigh benefits vs risks; not routine for BPD.

4) Bronchoscopy (diagnostic/therapeutic)
Procedure: Flexible scope passed into airways under careful monitoring.
Why done: To evaluate airway malacia, granulation, secretions, or foreign material and to aid clearance. Helps tailor ventilation and medication plans.

5) PDA closure (catheter or surgery) in select infants
Procedure: Device closure via catheter or surgical ligation.
Why done: A large, hemodynamically significant patent ductus arteriosus can worsen lung edema and ventilator needs; closure may improve breathing mechanics in select cases.

---

Preventions (simple, practical)

1. Antenatal steroids for mothers at risk of preterm birth to mature fetal lungs.

2. Gentle, non-invasive ventilation early to avoid intubation where possible.

3. Strict oxygen-saturation targeting to limit oxygen injury.

4. Use of surfactant in RDS when indicated with minimally invasive methods.

5. Infection prevention (hand hygiene, breast milk, line bundles).

6. Human milk feeding with fortification for growth and lung repair.

7. Avoid excess fluids; careful diuretic use only when needed.

8. Avoid routine acid suppression; use positioning for reflux first.

9. Timely RSV prophylaxis before discharge in season.

10. Family education and early follow-up to catch problems early.

---

When to See Doctors (parents/caregivers)

• Breathing becomes faster, noisy, or effortful (nostril flaring, chest retractions).

• New or higher oxygen need at home, or saturations falling below the plan range.

• Color changes (bluish lips/skin), pauses in breathing, or unusual sleepiness.

• Feeding takes too long, causes sweating or breathing pauses, or weight gain slows.

• Fever, cough, or known exposure to respiratory viruses.

• Swelling, poor urine output, or rapid weight changes (possible fluid issues).

• Any equipment alarms you cannot resolve quickly.

• You feel something “is not right”—trust your instincts and call.

---

What to Eat and What to Avoid

What to eat/receive (guided by NICU team):

1. Fortified human milk as the main nutrition.

2. Adequate protein modulars to meet growth goals.

3. Balanced fats including DHA/ARA per plan.

4. Micronutrients (vitamins A, D, E, iron, zinc, selenium) as prescribed.

5. Sufficient calories to support catch-up growth without large volumes.

What to avoid/limit:

1. Overfeeding large volumes that worsen reflux and desaturations.
2. Unsupervised supplements not prescribed for preterm infants.
3. High-sodium additives without clinical need (may worsen fluid retention).
4. Honey or unsafe foods for infants (botulism risk, choking).
5. Cow’s-milk–based additions not approved for preterm infants when human milk is available and fortifiable (follow team guidance).

---

Frequently Asked Questions (FAQs)

1) Will my baby outgrow BPD?
Many babies improve a lot in the first 2–3 years as lungs grow new air sacs. Some children wheeze more with colds and need inhalers. Regular follow-up helps keep progress steady.

2) Why does my baby still need oxygen at home?
Healing lungs need extra oxygen to prevent stress on the heart and brain. Home oxygen keeps saturations safe, reduces energy spent breathing, and supports growth.

3) Is BPD caused by the ventilator?
The ventilator is a tool that saves lives. Modern “gentle” settings and careful oxygen use aim to reduce injury while the lungs mature.

4) Can breastfeeding help?
Yes. Human milk lowers infections and supports growth. Fortification provides extra protein and minerals needed by preterm babies.

5) Why are diuretics used?
Some babies store extra lung water. Diuretics help remove fluid so breathing is easier. Doses are low and labs are checked for safety.

6) Will steroids harm my baby?
Steroids can help with severe lung swelling but have risks. Teams use the smallest effective dose for the shortest time after discussing benefits and risks with you.

7) How do we prevent RSV?
Hand hygiene, avoiding crowds during season, and antibody shots (as advised) help prevent severe RSV disease and hospitalization.

8) Why is growth so important?
Growth fuels lung repair and new tissue. Adequate protein and calories build respiratory muscles and new alveoli.

9) Do inhaled medicines always work?
Not always. Some babies respond to bronchodilators; others do not. Clinicians trial and measure the effect.

10) Are reflux medicines needed?
Not usually. Positioning and feed management come first. Acid blockers are used only for proven problems because they can raise infection risk.

11) Can we travel with home oxygen?
Yes, with planning. Your care team will help arrange portable systems, backup tanks, and travel letters.

12) Will my child need special school support?
Some children with a very early start benefit from early intervention services. Developmental clinics check milestones and recommend therapies if needed.

13) What happens during a cold?
Have an action plan: increase suctioning, monitor oxygen, and seek care early if breathing worsens or feeds suffer.

14) How long will my baby be on medicines?
Medicines are reviewed often. As lungs improve, many drugs are reduced or stopped. Never change doses without guidance.

15) What is pulmonary hypertension in BPD?
It is high pressure in lung blood vessels that can strain the heart. Specialists use echo to watch for it and treat if present.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 03, 2025.